Dermatology
Latest News
FDA extends Dupixent indication for 12- to 17-year-olds
While there are several systemic medications used as second-line therapy for treatment of pediatric AD, dupilumab is the first FDA-approved...
Case Reports
Sudden-onset rash on the trunk and limbs • morbid obesity • family history of diabetes mellitus • Dx?
► Sudden-onset rash on the trunk and limbs
► Morbid obesity
► Family history of diabetes mellitus
From the Journals
Fluorouracil beats other actinic keratosis treatments in head-to-head trial
A head-to-head study of four different actinic keratosis treatments has found 5% fluorouracil cream achieved the highest treatment success rate....
Photo Rounds
Sore on head
From the Journals
Comorbid skin conditions common in children with lichen nitidus
Lichen planus, lichen striatus, nail psoriasis, and cutaneuous atopy were the comorbid skin conditions in this cohort.
Conference Coverage
Atopic dermatitis at 1 year links with persistent food allergies
SAN FRANCISCO – Infants with atopic dermatitis at 1 year old that persists showed an elevated prevalence of food...
Conference Coverage
Food allergies and atopic dermatitis: What is the evidence?
WASHINGTON – Many patients believe that food allergy is what is driving their eczema, “and that’s the part we don’t really think bears out” in...
From the Journals
Don’t discount sleep disturbance for children with atopic dermatitis
Longitudinal data from more than 13,000 children show that those with atopic dermatitis suffer significantly impaired sleep quality.
Conference Coverage
Dermatologists name isobornyl acrylate contact allergen of the year
WASHINGTON – The adhesive ingredient is used in diabetes devices such as insulin pumps.
Conference Coverage
Pediatric pruritus requires distinct approach to assessment and management
WASHINGTON – Issues related to quality of life differ between children and adults, and assessing itch severity in...
Conference Coverage
Bermekimab reduces lesions, cuts pain in patients with hidradenitis suppurativa
WASHINGTON – The human monoclonal antibody is the first to target interleukin-1 alpha in the disorder.